You need to enable JavaScript to run this app.
Regulatory Recon: Astellas Acquires MitoBridge in $450M Deal National Academy of Sciences Report Lays Out Steps to Cut Drug Prices (1 December 2017)
Recon
Regulatory News
Michael Mezher